Breast cancer has been a long-standing and dangerous cancer affecting people all over the world. Up till now, early detection has been the most effective 'remedy'.
A new AI diagnostic for improving early detection has been invented in the UK by medical firm Digistain, has passed clinical studies and peer review, gaining market clearance from the Medicines & Healthcare Regulatory Agency (MHRA).
The creator of the technology and CEO of Digistain, Dr. Hemmel Amrania said: “Digistain is at the forefront of rapid and cost-effective personalised cancer treatment decision-making. This new technology speeds up a system that is currently too slow and where time and swift action are precious commodities.
For more on this advancement check out the full article by Med-Tech Innovation News here: med-technews.com